According to the report titled, ‘Global Proteomics Market - Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery, Others), End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’, available with Market Study Report LLC, global proteomics market was valued at USD  3.49 billion and is anticipated to record considerable growth over 2021-2026.
 

As per the report findings, global proteomics market expansion is largely fueled by widespread popularity of personalized medicines, rising expenditure in research and development activities, increasing government funding for proteomics, and subsequent technological developments.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4026313/
 

For the unversed, proteomics is the study of the structure of protein and its function. As proteins play a vital role in biological activities in human body, the measurement of its expression and role in healthy and diseased human beings is important to unveil novel scientific insights.
 

Additionally, profitable opportunities associated with biomarker identification, and ongoing developments in the field of mass spectrometry-based proteomics are further augmenting the industry outlook.
 

On the contrary, high cost of components and instruments used in this field, lack of skilled professionals, and stringent regulatory norms are likely to slow down the market progression in the ensuing years.
 

Based on component, global proteomics market is bifurcated into reagents, services, and instruments, whereas, segmentation on the basis of application includes drug discovery, clinical diagnostic, and others.
 

By end user, the industry sphere is fragmented into labs & clinics, hospitals, and others.
 

Regionally speaking, North America captured a 50.32% market share in 2020 and is expected to amass notable gains during 2021-2026.  This progress can be accredited to the presence of major market players, strong demand for high end research tools for data reproducibility, and rising focus towards introducing personalized therapeutics.
 

Furthermore, high investments to facilitate the development of structure-based drug design and increasing research activities in the field are also adding momentum to the expansion of the market in North America.
 

Key players operating in global proteomics market are Promega Corporation, WuXi AppTec Co. Ltd., Eurofins Scientific, GE Healthcare, Bruker Corporation, Agilent Technologies Inc., Qiagen N.V., Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., and Merck KGaA.